StockData
Fortrea Holdings Inc. logo

Fortrea Holdings Inc. (FTRE) stock

FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$19.59−0.20 (-1.01%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Fortrea ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Fortrea's ebitda for the twelve months ending Sep 30, 2026 was $91.50M. For fiscal 2025 it was -$794.60M. The highest annual figure on record is $280.70M in fiscal 2022.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$794.60M–
FY2024Dec 31, 2024-$75.00M-157.7%
FY2023Dec 31, 2023$130.00M-53.7%
FY2022Dec 31, 2022$280.70M+0.0%
FY2021Dec 31, 2021$280.60M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$35.00M+218.2%
Q2 FY2026Jun 30, 2026$34.40M–
Q1 FY2026Mar 31, 2026$16.40M–
Q4 FY2025Dec 31, 2025$5.70M–
Q3 FY2025Sep 30, 2025$11.00M+243.8%
Q2 FY2025Jun 30, 2025-$310.70M–
Q1 FY2025Mar 31, 2025-$500.60M–
Q4 FY2024Dec 31, 2024-$34.80M-8800.0%
Q3 FY2024Sep 30, 2024$3.20M-90.3%
Q2 FY2024Jun 30, 2024-$29.50M-153.6%
Q1 FY2024Mar 31, 2024-$13.90M-137.4%
Q4 FY2023Dec 31, 2023$400.00K-99.0%
Q3 FY2023Sep 30, 2023$33.10M-63.9%
Q2 FY2023Jun 30, 2023$55.00M-41.9%
Q1 FY2023Mar 31, 2023$37.20M–
Q4 FY2022Dec 31, 2022$38.20M–
Q3 FY2022Sep 30, 2022$91.60M–
Q2 FY2022Jun 30, 2022$94.60M–

More Fortrea figures

See a number that looks wrong?